Literature DB >> 74774

Disopyramide in renal impairment.

B Whiting, H L Elliott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 74774     DOI: 10.1016/s0140-6736(77)90418-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.

Authors:  C R Kumana; V S Rambihar; K Willis; R N Gupta; P H Tanser; J A Cairns; R A Wildeman; M Johnston; A L Johnson; M Gent
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of disopyramide.

Authors:  A Karim; C Nissen; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

3.  Pharmacokinetics of disopyramide in patients with chronic renal failure.

Authors:  B Francois; R Mallein; J Rondelet; M Lussignol
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

Review 4.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

5.  Haemodynamic effects of disopyramide in patients after open-heart surgery.

Authors:  N Naqvi; D S Thompson; W E Morgan; B T Williams; D J Coltart
Journal:  Br Heart J       Date:  1979-11

6.  Plasma concentrations and protein binding of disopyramide and mono-N-dealkyldisopyramide during chronic oral disopyramide therapy.

Authors:  M L Aitio
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 7.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 8.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

9.  Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?

Authors:  M L Aitio; T Vuorenmaa
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.